Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus
Clinical trial NCT01222078 · TERMINATED
Trial details
- NCT number
- NCT01222078
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-22
- Primary completion
- 2011-05-19
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.